Seres Therapeutics, Inc. (NASDAQ:MCRB) Q1 2021 Earnings Conference Call May 4, 2021 8:30 AM ET Company Participants Carlo Tanzi - Investor Relations Eric Shaff - Chief Executive Officer Lisa von Moltke - Chief Medical Officer Matthew Henn - Chief Scientific Officer David Ege - Chief Technology Officer Terri Young - Chief Commercial & Strategy Officer Conference Call Participants Mark Breidenbach - Oppenheimer Joe Thome - Cowen and Company Ted Tenthoff - Piper Sandler Chris Howerton - Jefferies Terence Flynn ...

Eric Shaff Chief Executive Officer 31st Annual Oppenheimer Healthcare Conference March 16, 2021 2 Forward Looking Statements Some of the statements in this presentation constitute "forward looking statements" under the Private Securities Litigation Reform Act of 1995, including, but not limited to, our development plans, the promise and potential impact of any of our microbiome therapeutics, the ability of our clinical trials to support approval, the timing and results of clinical studies, the timing and ul ...

Seres Therapeutics Corporate Overview March 2, 2021 Forward looking statements Some of the statements in this presentation constitute "forward looking statements" under the Private Securities Litigation Reform Act of 1995, including, but not limited to, our development plans, the promise and potential impact of any of our microbiome therapeutics, the ability of our clinical trials to support approval, the timing of clinical studies, the timing and ultimate results of the SER-109 safety data, the size of the ...

Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2020 Earnings Conference Call March 2, 2021 8:30 AM ET Company Participants Carlo Tanzi - IR Eric Shaff - President and CEO Lisa von Moltke - Chief Medical Officer Matthew Henn - Chief Scientific Officer Terri Young - Chief Commercial and Strategy Officer David Ege - Chief Technology Officer Conference Call Participants Ted Tenthoff - Piper Sandler Joseph Thome - Cowen & Company Mark Breidenbach - Oppenheimer Terence Flynn - Goldman Sachs Chris Howerton - Jefferies ...

Seres Therapeutics Eric Shaff, Chief Executive Officer 39th Annual J.P. Morgan Healthcare Conference January 14, 2021 Forward looking statements Some of the statements in this presentation constitute "forward looking statements" under the Private Securities Litigation Reform Act of 1995, including, but not limited to, our development plans, the promise and potential impact of any of our microbiome therapeutics, the ability of our clinical trials to support approval, the timing of clinical studies, the timin ...

Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2020 Earnings Conference Call November 9, 2020 8:30 AM ET Company Participants Carlo Tanzi - VP of IR & Corporate Communications Eric Shaff - President, CEO & Director Lisa von Moltke - EVP & Chief Medical Officer Matthew Henn - EVP & Chief Scientific Officer Terri Young - Chief Commercial and Strategy Officer Conference Call Participants Ted Tenthoff - Piper Sandler Joseph Thome - Cowen & Company John Newman - Canaccord Mark Breidenbach - Oppenheimer Chris Howerton ...

April 2020 Seres Therapeutics Overview Forward looking statements Some of the statements in this presentation constitute "forward looking statements" under the Private Securities Litigation Reform Act of 1995, including, but not limited to, our development plans, the promise and potential impact of any of our microbiome therapeutics or clinical trial data, the ability of our clinical trials to support approval, the timing of clinical studies, the sufficiency of cash to fund operations, and the potential ben ...

Seres Therapeutics, Inc. (NASDAQ:MCRB) Q1 2020 Earnings Conference Call May 7, 2020 8:30 AM ET Company Participants Carlo Tanzi - VP of IR & Corporate Communications Eric Shaff - President, CEO & Director Lisa von Moltke - EVP & Chief Medical Officer Matthew Henn - EVP & Chief Scientific Officer Conference Call Participants Chris Shibutani - Cowen Melissa Hilton - Goldman Sachs Matthew Biegler - Oppenheimer Gbola Amusa - Chardan John Newman - Canaccord Vernon Bernardino - H.C. Wainwright Roger Song - Jeffer ...

Seres Therapeutics Overview Eric Shaff, President and Chief Executive Officer Cowen Health Care Conference March 2, 2020 Forward looking statements Some of the statements in this presentation constitute "forward looking statements" under the Private Securities Litigation Reform Act of 1995, including, but not limited to, our development plans, the promise and potential impact of any of our microbiome therapeutics or clinical trial data, the ability of our clinical trials to support approval, the timing of c ...

Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2019 Results Earnings Conference Call March 2, 2020 8:30 AM ET Company Participants Carlo Tanzi - Investor Relations Eric Shaff - President and Chief Executive Officer Matt Henn - Chief Scientific Officer Conference Call Participants Pam Barrett - Cowen Mark Breidenbach - Oppenheimer John Newman - Canaccord Operator Ladies and gentlemen, thank you for standing by and welcome to the Fourth Quarter Seres Therapeutics Earnings Conference Call. At this time, all partici ...